Morgan Stanley Maintains Equal-Weight on Ovintiv, Lowers Price Target to $65

Benzinga Newsdesk www.benzinga.com Neutral 65.9%

Neg 0% Neu 65.9% Pos 0%

Morgan Stanley analyst Devin McDermott maintains Ovintiv (NYSE:OVV) with a Equal-Weight and lowers the price target from $68 to $65.